Go Deep
Sanara MedTech Inc.
Sanara MedTech Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | -6,372 | -878.5 | 40.65 | 6.12 | 3,346.51 |
| Oct 2026 | -6,357 | -878.0 | 40.62 | 6.12 | 3,334.56 |
| Oct 2026 | -6,310 | -877.2 | 40.59 | 6.12 | 3,332.18 |
| Oct 2026 | -4,873 | -829.0 | 38.35 | 6.12 | 3,140.75 |
| Oct 2026 | -4,859 | -828.5 | 38.33 | 6.12 | 3,142.22 |
| Oct 2026 | -4,859 | -828.5 | 38.33 | 6.12 | 3,142.22 |
| Oct 2026 | -4,583 | -819.2 | 37.90 | 6.12 | 3,099.46 |
| Oct 2026 | -4,665 | -822.0 | 38.03 | 6.12 | 3,103.57 |
| Oct 2026 | -4,606 | -820.0 | 37.94 | 6.12 | 3,108.86 |
Sanara MedTech Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 28,136,757.0 | 27,798,534.0 | 27,545,815.0 | 26,333,819.0 |
| Net Profit | -452,864.0 | 458,957.0 | -1,609,914.0 | -30,411,153.0 |
| EPS | -0.1 | 0.1 | -0.2 | -3.5 |
Sanara MedTech Inc. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 103,117,982.0 | 86,672,425.0 | 64,989,842.0 | 45,842,845.0 | — |
| Net Profit | -37,562,606.0 | -9,664,547.0 | -4,303,197.0 | -7,937,497.0 | — |
| EPS | -4.4 | -1.1 | -0.5 | -1.0 | — |
Sanara MedTech Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 72,944,071.0 | 88,091,992.0 | 73,871,149.0 | 61,035,386.0 | — |
| Total Liabilities | 67,014,295.0 | 49,180,030.0 | 29,283,132.0 | 19,315,411.0 | — |
| Total Equity | 5,938,442.0 | 39,403,573.0 | 44,832,277.0 | 41,827,530.0 | — |
Owes vs Owns
Sanara MedTech Inc. owed $0.89 for every $1 it owned in Jun 2026, up from $0.32 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.89× | 0.92× | 0.56× | 0.40× | 0.32× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Sanara MedTech Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 22.7%Receivables 16.4%Inventory 5.4%Fixed assets (tangible) 3.5%Intangible assets 30.5%Long-term investments 20.1%Other assets 1.4%
How it's funded — Dec 2025
Long-term debt 63.0%Payables 3.2%Other liabilities 25.2%Shareholders' equity 8.1%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 16.6 | 15.9 | 5.1 | 9.0 |
| Receivables | 12.0 | 13.6 | 8.5 | 7.0 |
| Inventory | 3.9 | 2.8 | 4.7 | 3.5 |
| Fixed assets (tangible) | 2.5 | 1.9 | 3.3 | 2.2 |
| Intangible assets | 22.2 | 27.1 | 48.5 | 35.1 |
| Long-term investments | 14.6 | 6.2 | 3.1 | 3.1 |
| Other assets | 1.0 | 20.7 | 0.6 | 1.1 |
| Liabilities & equity | ||||
| Short-term debt | 0.4 | 0.4 | 0.6 | 0.3 |
| Long-term debt | 46.0 | 30.7 | 9.1 | 0.5 |
| Payables | 2.3 | 1.5 | 2.0 | 1.4 |
| Other liabilities | 18.4 | 16.6 | 17.6 | 17.1 |
| Shareholders' equity | 5.9 | 38.9 | 44.6 | 41.7 |
| Net tangible assets | -16.3 | 12.3 | -3.7 | 6.7 |
Sanara MedTech Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | 6,786,629.0 | -23,784.0 | -3,245,556.0 | -5,554,870.0 | — |
| Investing Activities | -14,973,890.0 | -6,611,643.0 | -10,207,346.0 | -3,511,630.0 | — |
| Financing Activities | 8,887,823.0 | 17,366,506.0 | 9,641,123.0 | -627,346.0 | — |